Bristol Myers plans to launch schizophrenia drug in UK at list price equal to the US
百时美施贵宝(US:BMY) Reuters·2025-09-22 11:26Bristol Myers Squibb said on Monday that it plans to launch its schizophrenia treatment Cobenfy in the UK in 2026 at a price that is equal to its US list price. ...